AcquisitionOther

Vyant Bio, Inc. acquired U.S. Operations of Vyant Bio, Inc. Subsidiary

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Vyant Bio, Inc. -> U.S. Operations of Vyant Bio, Inc. Subsidiary · $5.5 million

~ ~ Transaction Expands Reaction Biology's Capabilities to Provide Customers with Solutions in Both the Discovery and Development of New Drug Candidates ~ ~ Transaction Provides Vyant Bio with Additional Capital to Deploy into Further Development of its Therap

Open source record (SEC) ↗